Life Saving Drugs Program resources – Late-Infantile onset batten disease (CLN2 disease)

A collection of resources for health professionals to help people with CLN2 disease access cerliponase alfa (Brineura®) under the Life Saving Drugs Program.

Collection description

This collection contains guidelines, forms and documents related to accessing cerliponase alfa (Brineura®) under the LSDP. Click to view the Brineura® product information on the Therapeutic Goods Administration website.



We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Health sector

Help us improve

If you would like a response please use the enquiries form instead.